Key result
Wearable cardioverter defibrillator use in post-myocardial infarction patients was associated with a median physical activity of 5568 steps/day, which increased by 67% over the 90-day prescription.
Why the study?
Wearable cardioverter defibrillators are equipped with accelerometers that track wear time and physical activity, and this study aimed to report on patient physical activity while wearing a WCD.
Does physical activity improve over time in post-myocardial infarction patients with LVEF ≤35% wearing a wearable cardioverter defibrillator?
Observational (n=1,952)
Does physical activity improve over time in post-myocardial infarction patients with LVEF ≤35% wearing a wearable cardioverter defibrillator?
Physical activity in post-MI patients with reduced LVEF is modest initially but improves significantly over a 90-day period, demonstrating the utility of WCD accelerometers for remote monitoring of patient functional status.
Activity recovery trackable via WCD accelerometers post-MI; supports remote monitoring utility but leaves outcome impact open.
PURPOSE: Wearable cardioverter defibrillators (WCDs) provide lifesaving defibrillation and are equipped with accelerometers, capable of providing information on patient wear time and physical activity (PA). The purpose of this study was to report on patient PA while wearing a WCD. METHODS: This study derived data from the WCD vendor in patients prescribed WCD post-myocardial infarction (MI) with left ventricular ejection fraction ≤35% in 2016. Using the device accelerometer, the relationship between wear time and PA was examined in a sample of consistent wearers of the WCD. Demographic variables, including sex and age, were examined for impact on wear time and PA. Changes in PA over time were also examined. RESULTS: A total of 1952 patients (71% male) with a median age of 63 yr were included. Descriptive analyses indicated that overall median wear time was 23.8 hr/d; PA was 5568 steps/d. Significant differences in PA over time were identified, with median steps increasing by 67% from the first week of wear to the last week of wear. Patient age and wear time significantly predicted PA; patient age also significantly predicted patient wear time. There were significant differences in median hours of wear time, as well as median steps, based on sex. CONCLUSIONS: PA in adults early after hospital discharge is modest and improves over the course of the 90-d WCD prescription in regular wearers. Improved health status may account for this change. The WCD accelerometer may have value in future clinical care and research by providing a window into daily patient PA levels via remote monitoring.
No takes yet. Share an insight, caveat, or question.
Tripp et al. (2020) conducted an observational in Post-myocardial infarction with left ventricular ejection fraction ≤35% (n=1,952). Wearable cardioverter defibrillator (WCD) was evaluated on Wear time and physical activity (steps/day). Wearable cardioverter defibrillator use in post-myocardial infarction patients was associated with a median physical activity of 5568 steps/day, which increased by 67% over the 90-day prescription.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: